Citicoline Injection IP

Trade Name: CiticVac
Available Strength : 1000 mg
Available Combination : Citicoline Injection IP is used to support brain health and improve cognitive function in neurological conditions.
Packing : 4 ml Amp.
Pack Insert/Leaflet : YES
Therapeutic use : Citicoline Injection IP is a neuroprotective and cognitive-enhancing agent used to support brain function and recovery in neurological conditions. It is commonly prescribed for stroke, traumatic brain injury, vascular dementia, and cognitive impairment, as it helps restore neuronal cell membrane integrity, enhances neurotransmitter synthesis, improves cerebral metabolism, and supports memory and cognitive function.
Capacity : 100000

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.